Denver Implements Ban on Flavored Tobacco Products to Protect Youth

Dec.20.2024
Denver Implements Ban on Flavored Tobacco Products to Protect Youth
Denver Mayor Mike Johnston signed a bill banning flavored tobacco and nicotine products in the city and county.

According to a report from the Denver Gazette on December 19, the mayor of Denver, Colorado, Mike Johnston, officially signed a bill passed by the Denver City Council on Monday, December 16, banning the sale and distribution of flavored tobacco and nicotine products in the city and county of Denver.


The bill was passed by the city council with a vote of 11 in favor and 1 against, stating that any retail tobacco shop is prohibited from "selling, offering for sale, giving away, exchanging, delivering, or supplying any flavored tobacco product or its samples." Mayor Johnston stated that if the bill passes, he will support the measure.


In a news statement, the Campaign for Tobacco-Free Kids believes this indicates that "Denver is prioritizing the profits of the tobacco industry over the well-being of youth and the entire community.


Opponents point out that the comprehensive ban could potentially threaten small businesses, leading to job loss, decreasing urban sales tax revenue, and increasing crime activity in the Denver community.


The law will come into effect 90 days from now in order for the public health and environmental departments to educate businesses and encourage them to voluntarily comply. The Denver Health Department said that the law will not take effect until 2026.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Rutgers Study Finds Adult Nicotine Pouch Use Is Low but Concentrated Among Recent Quitters, Suggesting Harm-Reduction Potential
Rutgers Study Finds Adult Nicotine Pouch Use Is Low but Concentrated Among Recent Quitters, Suggesting Harm-Reduction Potential
Researchers at Rutgers Health report the first national estimates of daily nicotine-pouch use among U.S. adults, finding overall use remains low but is most common among people with a history of tobacco use—especially those who recently quit. The cross-sectional analysis, published in JAMA Network Open, uses 2022–2023 Tobacco Use Supplement data (>110,000 adults) to establish a baseline for future trends. Contextual data show the FDA authorized marketing for 20 ZYN pouch products in January 2025
Sep.09
Philip Morris South Africa calls for science-based tobacco regulation, emphasizing a "risk-proportionate" framework to accelerate smoking rate reduction
Philip Morris South Africa calls for science-based tobacco regulation, emphasizing a "risk-proportionate" framework to accelerate smoking rate reduction
Philip Morris International (PMI) South Africa calls for scientific regulation of e-cigarettes to promote tobacco harm reduction.
Aug.29 by 2FIRSTS.ai
Danbury, Connecticut Conducts Raids on Four Vape Shops: Underage Sales and Suspected Illegal Cannabis Products Found
Danbury, Connecticut Conducts Raids on Four Vape Shops: Underage Sales and Suspected Illegal Cannabis Products Found
Police in Danbury, Connecticut, conducted surprise inspections with multiple agencies at four vape shops and found several violations, including selling tobacco products to minors and the alleged illegal sale of cannabis products. One store was ordered to close for violating labor laws. Mayor Roberto Alves said the city will continue to strengthen enforcement and zoning controls to curb threats to youth health.
Sep.16 by 2FIRSTS.ai
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada stated that one year ago, the government removed the nicotine pouch ZONNIC from convenience stores, restricting sales to behind-the-counter in pharmacies. This move caused ZONNIC sales to plummet, cigarette sales to rebound by 2.8%, and was accompanied by a surge of high-dose illegal nicotine pouches and black-market cigarettes (exceeding 500 million packs annually). The company is calling for an evidence-based harm reduction approach to restore multi-channel supply throu
Aug.20 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores
FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores
FDA launches national retail compliance initiative to combat illegal e-cigarette sales targeting youth, issuing guidance materials to over 300k retailers.
Oct.08 by 2FIRSTS.ai